Adherence to Medication in Patients With Acute Decompensated Heart Failure
Launched by UNIVERSITÄT DES SAARLANDES · Jun 10, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well patients with acute heart failure are sticking to their prescribed heart failure medications. Heart failure can worsen for many reasons, and one of them may be that patients are not taking their medications as directed. Researchers want to see how often patients are adhering to their medications using a precise testing method at the emergency department. They will also use questionnaires to understand what might affect a patient's ability to take their medications regularly.
To be eligible for this study, participants must be at least 18 years old and have a known history of chronic heart failure. They should require intravenous diuretics, which are medications that help remove excess fluid, and they must have been stable on their heart failure medications for at least two weeks. Additionally, participants need to show at least one sign of fluid overload, like swelling or difficulty breathing, and have elevated levels of a specific protein in their blood. If you join this trial, you can expect to provide some information about your health and medications, while also contributing to important research that could help improve care for others with heart failure.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age ≥18 years of age
- • known chronic heart failure irrespective of ejection fraction (heart failure with reduced, mildly reduced, or preserved ejection fraction)
- • requirement of intravenous diuretics (outpatient or stationary treatment)
- • stable heart failure medication \>2 weeks
- • ≥1 sign of volume overload (peripheral edema, jugular venous distension, pulmonary rales, ascites, or demonstration of pulmonary venous congestion on chest X-ray)
- • elevated natriuretic peptides (N-terminal pro brain natriuretic peptide= nt-pro-BNP ≥125 pg/ml)
- Exclusion Criteria:
- • - Not able to give written informed consent
About Universität Des Saarlandes
The Universität des Saarlandes is a distinguished academic institution located in Germany, recognized for its commitment to advancing research and education in the medical and health sciences. As a clinical trial sponsor, the university leverages its robust interdisciplinary expertise and state-of-the-art facilities to facilitate innovative research initiatives aimed at addressing critical health challenges. The institution fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring rigorous adherence to ethical standards and regulatory compliance throughout the clinical trial process. Through its dedication to scientific excellence and patient-centered research, Universität des Saarlandes plays a vital role in contributing to the development of novel therapeutic interventions and improving healthcare outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Homburg, , Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported